Base Editing Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Germany,UK,China,Japan - Size and Forecast 2024-2028

Published: Dec 2023

Pages: 148

SKU: IRTNTR77164

Snapshot

Base Editing Market 2024-2028

The Global Base Editing Market size is forecast to increase by USD 307.66 million, at a CAGR of 15.1% between 2023 and 2028.

There has been an increase in applications of genome editing in therapeutics. In addition, researchers are working on new gene-based therapies to reduce the morbidity and mortality among HIV-infected patients. Moreover, base editing can provide therapeutic tools for this disease. Furthermore, CRISPR technologies can offer anti-retroviral therapies to inhibit the virus with reduced treatment interventions. Hence, such factors are positively impacting the market.

What will be the Size of the Base Editing Market During the Forecast Period?

To learn more about this report, Download Report Sample

Base Editing Market Segmentation by Application, Type, and Geography Analysis

Application Analysis

Drug discovery and development

The drug discovery and development segment is estimated to witness significant growth during the forecast period. The market growth of the drug discovery and development segment is fuelled by the growing pharmaceutical and biotechnology industry's increasing R&D expenditure and increasing research on molecular biology toward drug discovery and development. In addition, biotechnology and pharmaceutical companies are investing huge amounts in R&D activities for drug discovery of genetic diseases along with the increasing prevalence of neurological disorders.

Get a glance at the market contribution of various segments Download PDF Sample

The drug discovery and development segment was the largest segment and was valued at USD 80.47 million in 2018. Moreover, the market players are focused on investments in genome editing for drug testing, high-throughput screening, and developing innovative drug formulations. In addition, there is an increase in focus on drug discovery and development by pharmaceutical and biotechnology companies as well as by research institutes for several diseases, propelling the demand for base editing services. Furthermore, base editing finds applications such as target classification, target authentication, and analyzing pathways, compound profiling, and toxicology studies, which are critical in drug discovery and development.

Hence, such factors are fueling the growth of this segment which, in turn, drives the market growth and forecasting during the forecast period. Additionally, market analysis and report indicate a positive outlook for the expansion of the drug discovery and development segment in the foreseeable future.

Type Analysis

DNA base editing

The market growth of the DNA base editing segment is fueled by the growing adoption of DNA sequencing. In addition, DNA sequencing is gaining prominence in many areas, including biology and other sciences, such as forensics, anthropology, and medicine, due to its increasing number of applications. Moreover, DNA sequencing has a wide range of applications that range from the determination of the entire genome of any organism to the sequencing of individual genes. Furthermore, DNA base editing is widely used in medicine to determine the risks of certain genetic diseases in patients and to identify specific infection-causing bacteria to decide on the correct antibiotic treatment, thereby reducing the risk of antibiotic resistance.

Hence, such factors are fueling the growth of this segment, which in turn drives the market growth and forecasting during the forecast period. Additionally, precision editing and targeted mutagenesis techniques in genome engineering contribute significantly to the advancement and expansion of the DNA base editing segment in various scientific and medical applications.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market growth in North America is fuelled by the huge investment in R&D activities for gene therapy, especially in the US. In addition, the region holds strong potential for base editing due to hundreds of clinical trials being performed in the region, more specifically in the US, to treat cancer, human immunodeficiency virus (HIV) acquired immunodeficiency syndrome (AIDS), and other diseases. Furthermore, incidences of cancer have increased significantly in countries across North America over the years. Therefore, the high incidence of various types of cancers has increased the demand for several treatment procedures. Hence, such factors have increased the demand for base editing, which, in turn, is anticipated to drive the growth of the market in North America during the forecast period.

Buy Full Report Now

Key Base Editing Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Beam Therapeutics Inc: The company offers base editing solutions such as the REPAIR system for A to I editing and the RESCUE system for C to U editing.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The base editing market represents a groundbreaking frontier in genetic engineering, offering precise tools for genome modification and gene editing. Leveraging technologies like Cas9 nuclease, base editing enables targeted alterations in DNA, facilitating therapeutic applications in precision medicine.

With its potential in gene correction and gene regulation, base editing holds promise for advancing cell therapy and other medical interventions. As the field evolves, stakeholders closely monitor market trends and analysis to identify emerging opportunities and challenges. Market research and growth initiatives drive innovation and foster collaboration within the industry.

Strategic planning is informed by market forecasting insights and market analysis reports, guiding stakeholders in navigating market growth and trends. Together, these efforts contribute to the sustainable development and expansion of the market.

Base Editing Market: Trends, Challenges, and Customer Landscape

Key Market Trends

A key factor shaping the market growth is the technological advancement in genome editing tools. Several technological advances in the CRISPR-Cas9 base editing technology support biological and biomedical research. For example, in June 2020, E. Merck KG and 10X Genomics jointly announced the development of a new option for biological experiments, which combines the genome-editing technology offered by E. Merck KG with the Feature Barcode technology from 10X Genomics for screening single cells using CRISPR libraries.

Moreover, CRISPR systems are derived from bacteria and need to be re-engineered for use in human cells. In addition, proxy-CRISPR provides a rapid and simple method to increase its use without the time-consuming task of re-engineering native CRISPR proteins, which makes proxy-CRISPR more efficient, flexible, and specific than CRISPR systems. Hence, the continuous advancements in base editing tools will fuel their adoption in biological and biomedical research, contributing to market growth analysis during the forecast period.

Key Market Challenges

Inherent issues in genome editing are one of the key challenges hindering market growth. CRISPR technologies are crucial for base editing due to their simplicity and efficiency. However, it has several disadvantages which are negatively impacting the market. For instance, base editing is used to insert or delete DNA fragments that are mediated by the DNA repair mechanism activated by endonucleases like Cas9.

Moreover, as the quality of genome editing tools is yet to be optimized, targeted alleles may also carry additional modifications like multiple integrations of target vectors, deletions, and duplications of DNA fragments. Thus, as it is impossible to select the desired event while using CRISPR technology, it is challenging to perform experiments on human embryos. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Base Editing Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

Application Outlook
- Drug discovery and development
- Agriculture
- Veterinary
Type Outlook
- DNA base editing
- RNA base editing
Geography Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Australia
  - Argentina
  - Brazil

Base Editing Market Scope
Report Coverage	Details
Page number	148
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 15.1%
Market Growth 2024-2028	USD 307.66 million
Market structure	Fragmented
YoY growth 2023-2024(%)	13.51
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 35%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Beam Therapeutics Inc., Bio Palette Co. Ltd., Cellectis SA, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore Co. Ltd., GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., KromaTiD Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise Plants Services, PerkinElmer Inc, ProQR Therapeutics NV, QI Biodesign Biotechnology Co. Ltd., Shape Therapeutics Inc., and Synthego Corp.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Base Editing Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2024 and 2028
Precise estimation of the market size and its contribution to the market in focus to the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global base editing market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global base editing market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Drug discovery and development - Market size and forecast 2023-2028
- Exhibit 34: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)

6.4 Agriculture - Market size and forecast 2023-2028
- Exhibit 38: Chart on Agriculture - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Agriculture - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Agriculture - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Agriculture - Year-over-year growth 2023-2028 (%)

6.5 Veterinary - Market size and forecast 2023-2028
- Exhibit 42: Chart on Veterinary - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Veterinary - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Veterinary - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Veterinary - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Application
- Exhibit 46: Market opportunity by Application ($ million)
- Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 48: Chart on Type - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type
- Exhibit 50: Chart on Comparison by Type
- Exhibit 51: Data Table on Comparison by Type

7.3 DNA base editing - Market size and forecast 2023-2028
- Exhibit 52: Chart on DNA base editing - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on DNA base editing - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on DNA base editing - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on DNA base editing - Year-over-year growth 2023-2028 (%)

7.4 RNA base editing - Market size and forecast 2023-2028
- Exhibit 56: Chart on RNA base editing - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on RNA base editing - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on RNA base editing - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on RNA base editing - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Type
- Exhibit 60: Market opportunity by Type ($ million)
- Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Beam Therapeutics Inc.
- Exhibit 111: Beam Therapeutics Inc. - Overview
- Exhibit 112: Beam Therapeutics Inc. - Product / Service
- Exhibit 113: Beam Therapeutics Inc. - Key offerings

12.4 Bio Palette Co. Ltd.
- Exhibit 114: Bio Palette Co. Ltd. - Overview
- Exhibit 115: Bio Palette Co. Ltd. - Product / Service
- Exhibit 116: Bio Palette Co. Ltd. - Key offerings

12.5 Cellectis SA
- Exhibit 117: Cellectis SA - Overview
- Exhibit 118: Cellectis SA - Product / Service
- Exhibit 119: Cellectis SA - Key offerings

12.6 Creative Biogene
- Exhibit 120: Creative Biogene - Overview
- Exhibit 121: Creative Biogene - Product / Service
- Exhibit 122: Creative Biogene - Key offerings

12.7 Danaher Corp.
- Exhibit 123: Danaher Corp. - Overview
- Exhibit 124: Danaher Corp. - Business segments
- Exhibit 125: Danaher Corp. - Key news
- Exhibit 126: Danaher Corp. - Key offerings
- Exhibit 127: Danaher Corp. - Segment focus

12.8 EdiGene Inc.
- Exhibit 128: EdiGene Inc. - Overview
- Exhibit 129: EdiGene Inc. - Product / Service
- Exhibit 130: EdiGene Inc. - Key offerings

12.9 ElevateBio
- Exhibit 131: ElevateBio - Overview
- Exhibit 132: ElevateBio - Product / Service
- Exhibit 133: ElevateBio - Key offerings

12.10 GenScript Biotech Corp.
- Exhibit 134: GenScript Biotech Corp. - Overview
- Exhibit 135: GenScript Biotech Corp. - Business segments
- Exhibit 136: GenScript Biotech Corp. - Key news
- Exhibit 137: GenScript Biotech Corp. - Key offerings
- Exhibit 138: GenScript Biotech Corp. - Segment focus

12.11 Intellia Therapeutics Inc.
- Exhibit 139: Intellia Therapeutics Inc. - Overview
- Exhibit 140: Intellia Therapeutics Inc. - Product / Service
- Exhibit 141: Intellia Therapeutics Inc. - Key offerings

12.12 Maravai LifeSciences Holdings Inc.
- Exhibit 142: Maravai LifeSciences Holdings Inc. - Overview
- Exhibit 143: Maravai LifeSciences Holdings Inc. - Business segments
- Exhibit 144: Maravai LifeSciences Holdings Inc. - Key offerings
- Exhibit 145: Maravai LifeSciences Holdings Inc. - Segment focus

12.13 Merck KGaA
- Exhibit 146: Merck KGaA - Overview
- Exhibit 147: Merck KGaA - Business segments
- Exhibit 148: Merck KGaA - Key news
- Exhibit 149: Merck KGaA - Key offerings
- Exhibit 150: Merck KGaA - Segment focus

12.14 PerkinElmer Inc
- Exhibit 151: PerkinElmer Inc - Overview
- Exhibit 152: PerkinElmer Inc - Business segments
- Exhibit 153: PerkinElmer Inc - Key news
- Exhibit 154: PerkinElmer Inc - Key offerings
- Exhibit 155: PerkinElmer Inc - Segment focus

12.15 ProQR Therapeutics NV
- Exhibit 156: ProQR Therapeutics NV - Overview
- Exhibit 157: ProQR Therapeutics NV - Product / Service
- Exhibit 158: ProQR Therapeutics NV - Key offerings

12.16 Shape Therapeutics Inc.
- Exhibit 159: Shape Therapeutics Inc. - Overview
- Exhibit 160: Shape Therapeutics Inc. - Product / Service
- Exhibit 161: Shape Therapeutics Inc. - Key offerings

12.17 Synthego Corp.
- Exhibit 162: Synthego Corp. - Overview
- Exhibit 163: Synthego Corp. - Product / Service
- Exhibit 164: Synthego Corp. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 165: Inclusions checklist
- Exhibit 166: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 167: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 168: Research methodology
- Exhibit 169: Validation techniques employed for market sizing
- Exhibit 170: Information sources

13.5 List of abbreviations
- Exhibit 171: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

base editing market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis